Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Phosphorus containing other than solely as part of an...
Patent
1990-07-20
1992-03-10
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Phosphorus containing other than solely as part of an...
514 89, 514 92, 514114, 544337, 546 22, 548119, 558169, 562 11, A61K 31675, C07F 96509, C07F 9653, C07F 938, C07F 940
Patent
active
050950096
ABSTRACT:
The present invention is directed to a new class of 4-(oxoalkyl)phosphono, 4(oxime alkyl)phosphono, or 4-(hydrazine alkyl)phosphono, 2-piperazine carboxylic derivatives that are useful as NMDA antagonists
REFERENCES:
patent: 4705781 (1987-11-01), Boast
Derwent Abstract 88-251354/36 (Abstract of DE 3804-936-A).
Bennett et al., Life Sciences, vol. 39, pp. 2455-2461.
Pike et al., Biochimica et Biophysica Acta. 708 (1982) 203-209.
Baron Bruce M.
Whitten Jeffrey P.
Bernhardt E.
Bond Robert T.
Dixon J. Michael
Merrell Dow Pharmaceuticals Inc.
LandOfFree
NMDA antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with NMDA antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and NMDA antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2284636